Cargando…
Single-dose azithromycin microsphere formulation: a novel delivery system for antibiotics
Azithromycin extended release (Zmax(®), Pfizer Inc) is a novel single-dose administration formulation of azithromycin which won FDA approval in June 2005 and is currently approved for the treatment of community acquired pneumonia and acute bacterial sinusitis. Azitromycin is incorporated into sustai...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673814/ https://www.ncbi.nlm.nih.gov/pubmed/17722506 |